✦ LIBER ✦

Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the french society of paediatric oncology

✍ Scribed by J.-C. Gentet; M. Brunat-Mentigny; M.C. Demaille; F. Pein; H. Avet-Loiseau; C. Berger; L. De Lumley; H. Pacquement; C. Schmitt; E. Sariban; P. Pillon; J.L. Bernard; C. Kalifa

Book ID: 117663670
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 526 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(96)00439-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of ifosfamide in childhoo

Phase II study of ifosfamide in childhood brain tumors: A report by the French society of pediatric oncology (SFOP)

✍ Chastagner, Pascal ;Sommelet-Olive, Danièle ;Kalifa, Chantal ;Brunat-Mentigny, M 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB

## Abstract Forty‐two evaluable pediatric patients with a variety of recurrent primary brain tumors participated in a phase II ifosfamide trial. Their mean age was 10 years. All patients were treated with ifosfamide, 3 g/m^2^/day for 2 days every 2 weeks. Response was assessed on clinical and radio

Ifosfamide/etoposide combination in the

Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A pediatric oncology group phase II study

✍ Faith H. Kung; Charles B. Pratt; Roger A. Vega; Norman Jaffe; Douglas Strother; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Background. The prognosis for children with recurrent or resistant malignant solid tumors remains dismal. More effective rescue therapy is needed for these children. Methods. Between August 1987 and November 1990, 311 children with recurrent or resistant malignant solid tumors were treated by inves

Phase II/III Trial of Etoposide and High

Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial

✍ Goorin, A. M. 📂 Article 📅 2002 🏛 American Society of Clinical Oncology 🌐 English ⚖ 80 KB

Ifosfamide/Carboplatin/Etoposide (ICE),

Ifosfamide/Carboplatin/Etoposide (ICE), an effective salvaging therapy for recurrent malignant non-Hodgkin lymphoma of childhood: A Pediatric Oncology Group phase II study

✍ Kung, Faith H.; Harris, Michael B.; Krischer, Jeffrey P. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

nary observations on ICE as salvaging therapy for refractory NHL are encouraging. More study is needed to confirm our findings and to delineate which subtypes of NHL are most responsive to ICE therapy.

Topotecan as a radiosensitizer in the tr

Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas : Results of a French Society of Paediatric Oncology Phase II Study

✍ Valerie Bernier-Chastagner; Jacques Grill; Francois Doz; Serge Bracard; Jean Cla 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract ## BACKGROUND The current Phase II study was conducted to evaluate the survival and toxicity observed in children with newly diagnosed brainstem gliomas who were treated with the daily radiotherapy with topotecan used as a radiosensitizer. ## METHODS Eligible patients were those ages

Carboplatin and VP 16 in medulloblastoma

Carboplatin and VP 16 in medulloblastoma: A phase II study of the French Society of Pediatric Oncology (sfop)

✍ Gentet, Jean Claude ;Doz, François ;Bouffet, Eric ;Plantaz, Dominique ;Roché, He 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

## Abstract The purpose of this study is to evaluate the antitumor activity of combination carboplatin and etoposide in measurable medulloblastoma. From January '89 to January '92, 26 patients with medulloblastoma were included in a multicentric phase II study of 2 courses of carboplatin 160 mg/m^2